Profiel
Marina Wolfson is currently Chief Financial Officer at Energix-Renewable Energies Ltd. since 2026.
Former positions include Chief Financial Officer at BiomX, Inc. from 2020 to 2026, Finance Director at BioView Ltd. in 2010, and Senior Auditor at Kost Forer Gabbay & Kasierer and ERNST & YOUNG LTD from 2007 to 2010.
Education includes undergraduate and MBA degrees from Ben-Gurion University of the Negev.
Actieve functies van Marina Wolfson
| Bedrijven | Functie | Begin |
|---|---|---|
| ENERGIX - RENEWABLE ENERGIES LTD. | Financieel Directeur/CFO | 13-08-2026 |
Eerdere bekende functies van Marina Wolfson
| Bedrijven | Functie | Einde |
|---|---|---|
| BIOMX INC. | Financieel Directeur/CFO | 24-02-2026 |
| BIOMX INC. | Financieel Directeur/CFO | 01-11-2023 |
| BIO-VIEW LTD | Financieel Directeur/CFO | 01-01-2019 |
Kost Forer Gabbay & Kasierer
Kost Forer Gabbay & Kasierer Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Corporate Officer/Principal | 01-01-2010 |
Opleiding van Marina Wolfson
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Kost Forer Gabbay & Kasierer
Kost Forer Gabbay & Kasierer Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
Ben-Gurion University of the Negev
Ben-Gurion University of the Negev Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioView Ltd.
BioView Ltd. Medical SpecialtiesHealth Technology Manufactures and markets automated cell diagnostic system for use in cytology | Health Technology |
Energix-Renewable Energies Ltd.
Energix-Renewable Energies Ltd. Alternative Power GenerationUtilities Constructs, manages and sells electricity and solar energy systems | Utilities |
BiomX, Inc.
BiomX, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company developing natural and engineered phage cocktails designed to target and destroy bacteria that affect the appearance of skin | Health Technology |
















